Brief: Harbour Biomed Announces IND Clearance For HBM9027 In The U.S.
24/01/2024 04:41
Jan 23 (Reuters) - Hbm Holdings Ltd 2142.HK :
* HARBOUR BIOMED ANNOUNCES IND CLEARANCE FOR HBM9027 IN THE
U.S.
Source text for Eikon: ID:nPn98zlyYa
Further company coverage: 2142.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study